Sotac Pharmaceuticals IPO Particulars & Guidance at Chanakyanipothi.com, the Oldest & the most Trusted Investment website in India for coming up IPOs. Operational since 8th December 1999, this is the Only Investment Platform in India, which has successfully completed 23 Years.
Sotac Pharmaceuticals IPO Listing:
The scrip received marginal positive listing as mentioned by us in our guidance. Compared to issue price of Rs.111, the scrip listed at Rs. 115.
Sotac Pharmaceuticals IPO Guidance:
Gujarat based company has shown steady rise in its turnover and bottomline. The IPO size is large and due to weak market mood, bumper oversubscription is not expected. There is not much fancy seen in the grey market. Marginal positive listing is expected.
Sotac Pharmaceuticals IPO Grey Market updates
Prior to listing
GMP: Rs.10/11 few trades seen
Subject to: No Trades
Sotac Pharmaceuticals IPO Subscription Status
On 3 April 2023 @ 3.00 (Closed)
QIB(net) 570000 Shares, 1.00T
NII: 428400 Shares, 4.04T
RII: 998400 Shares,0.91T
Total: 2850000 Shares 1.60T
Sotac Pharmaceuticals IPO Particulars & Guidance: About the business
SOTAC Group is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-lactam Syrup and external preparations through issuer company SOTAC Pharmaceuticals Limited. Beta-lactam coated tablets, beta-lactam uncoated tablets, betalactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and cream through 71% subsidiary company through SOTAC Healthcare Private Limited. It will be commencing manufacturing of Nutraceuticals
products and food products through newly incorporated 51% subsidiary SOTAC Lifescience Private Limited. The company is committed to provide a wide range of quality and affordable pharmaceutical products to a large number of healthcare professionals.
The group’s therapeutic portfolio includes Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, Anti Pyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams & Non-IP-Lactams, Anti-Fungal, Cephalosporin.
The group’s past and present clientele includes renowned pharma marketers and manufactures namely Cadila Pharma, J. B. Chemical, Lincoln Pharma, Intas Pharma, Viatris (Mylan), Makers (Ipca), Corona Remedies, Eris Lifesciences, Stride Pharma, Stalion Pharma, Acme Pharma, Olecare Pharma, Treatwell Pharma, Ronak Healthcare, Curever Pharma, Kentoss Pharma, Sunrest Pharma, Ishan Healthcare etc.
The pharmaceutical manufacturing facilities are situated at Sanand GIDC–II in Ahmedabad district of Gujarat, which offers easy and convenient accessibility. Its infrastructure consists of comprehensive production unit, quality control department quality assurance microbiological laboratory, raw material and finished product storage. The group’s manufacturing facilities are WHO-GMP accredited. In past, the manufacturing facility was also accredited with Kenya PPB and Ivory coast. SOTAC Pharmaceuticals Limited is also registered in USA with DUNS number.
For more information about the company, Click www.sotacpharma.com
Sotac Pharmaceuticals IPO Details | |
IPO opens on | 29 March 2023 |
IPO closes on | 03 April 2023 |
Issue Type | Book Built Issue IPO |
Issue Size | 3000000 Sh /Rs 33.30 Cr |
* Fresh Issue | 3000000 Sh /Rs 33.30 Cr |
* Offer for Sale | – Sh /Rs – Cr |
Face Value per share: | Rs. 10 |
Price Band | Rs.105-111 |
Employee discount | Rs. 0 per share |
Retail Lot Size | 1200 Shares |
Listing will at | NSE Sme |
Shares offered to | ||
Shares | Rs. (Cr) | |
QII (50 %) | 1425000 | 15.82 |
NII (15 %) | 427500 | 4.75 |
RII (35 %) | 997500 | 11.07 |
Total Shares | 2850000 | 31.64 |
Retail portion will be oversubscribed by | 831 | |
Forms | ||
How much Shares to Apply? | ||
Min Retail Application | 1200 Sh | Rs. 133200 |
Min HNI Application | 2400 Sh | Rs. 266400 |
Promoters of the IPO
Mr. Sharadkumar D. Patel, Mr. Dineshkumar B. Gelot, Mr. Vishalkumar D. Patel, Mr. Chetankumar B. Patel & Mrs. Kiran Baldevbhai Jotania
Objects of the IPO:
The Company proposes to utilize the Net Proceeds from the Issue towards
1. To Meet Working Capital Requirements
2. Investment in Subsidiary
3. Upgradation / Construction of Existing /New Building in the Existing Premises
IPO Tentative timetable | |
IPO opens on | 29 March 2023 |
IPO Closes on | 03 April 2023 |
IPO Allotment on | 10 April 2023 |
Unblocking of ASBA | 11 April 2023 |
Credit of Shares | 12 April 2023 |
Listing on | 13 April 2023 |
Registered Office of the Company Plot No. PF-21, Nr. ACME Pharma, Opp. Teva Pharma Sanand GIDC-II, Sanand Ahmedabad -382110, Gujarat, India |
IPO Lead Managers |
Beeline Capital Advisors Private Limited |
Registrar to the IPO |
KFin Technologies Limited |
IPO Financial & Analytical Ratios | ||||
Year | Total Income | Net Profit | EPS | RoNW |
Rs.in Cr | Rs.in Cr | Rs. | % | |
2019-20 | 28.76 | 0.71 | 1.05 | 20.93 |
2020-21 | 43.52 | 0.86 | 1.07 | 20.43 |
2021-22 | 73.37 | 2.88 | 3.58 | 43.47 |
Book Value of the Share on | 31.03.2022 | Rs.8.23 | ||
Book Value of the Share | after the IPO | Rs.- | ||
Offer Price | Rs. 111 |
Ratio Analysis | |
Upper Price/last EPS | 31.01 |
Upper price/BV Ratio | – |
Upper price/BV after IPO | 13.48 |
–
Sotac Pharmaceuticals IPO Particulars & Guidance
Peer Comparison:
As on date of DRHP | FV | Income | PE |
Rs. | in Cr | Ratio of | |
The IPO Company | 10 | 73.15 | 31.01 |
Lincoln Pharmaceuticals | 10 | 472.08 | 9.14 |
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
>>Go to Mainboard IPOs Section: Click
>>Get Good Staff or Job, Click: Staffavailable.com
>>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
>>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
>>Study Stock Research Reports, Click: AnalysisLibrary.com
>>Interested in Crossword Puzzles? Click: Magajmari.com